F-18 Fluoroestradiol (CERIANNA) for detection of estrogen receptor-positive lesions in Breast Cancer

Course overview

This course covers the official drug name, clinical indications, and a technical description of this diagnostic radiopharmaceutical; gives a description of the emissive properties of F-18 and information regarding its penetrability in human tissue; covers contraindications and side effects and adverse reactions related to this drug; the dose administration procedure; imaging procedures; pharmacology; and internal radiation dosimetry associated with the administration of F-18 Fluoroestradiol After completion of this course, one should be able to List the primary indication for diagnostic use of F-18 Fluoroestradiol; Identify the route of administration, the typical prescribed dose, and the clinical pharmacology; Describe imaging protocols; identify normal and abnormal images; and give a brief summary of internal radiation dosimetry following administration of F-18 Fluoroestradiol